Quadrature Capital’s Mural Oncology MURA Stock Holding History

Quadrature Capital’s Portfolio MURA Stock Details MURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-39,285	Closed	-$97.6K	–	1327
2025 Q2	$97.6K	Buy	+39,285	New	+$92.6K	﹤0.01%	894

Other funds holding MURA

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return

OAC

OMERS Administration Corp Toronto, Ontario, Canada $15.6B AUM 24.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Rangeley Capital New Canaan, Connecticut $103M AUM 77.32% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

DAM

Deltec Asset Management New York $677M AUM 31.67% 1-Year Est. Return

Quadrature Capital's MURA Position: Q3 2025 in Review

Quadrature Capital sold out of Mural Oncology (MURA) in Q3 2025, closing a stake of 39,285 shares — an estimated $97.6K sold.

Quadrature Capital first reported a position in MURA in Q2 2025 and held it in 1 quarter. The position peaked at $97.6K in Q2 2025. 61 funds tracked by Wall St. Rank hold MURA as of Q3 2025.

Quadrature Capital reported no remaining Mural Oncology position as of Q3 2025 after selling out during the quarter.
Quadrature Capital sold 39,285 Mural Oncology shares in Q3 2025, an estimated $97.6K.
Quadrature Capital first reported a position in Mural Oncology in Q2 2025 and held it in 1 quarter.
Quadrature Capital's Mural Oncology position peaked at $97.6K in Q2 2025.
61 funds tracked by Wall St. Rank held Mural Oncology as of Q3 2025.

Based on Quadrature Capital's 13F filing for Q3 2025, filed 13 Nov 2025.